NCT06044506View on ClinicalTrials.gov

Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 29, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Autologous Natural Killer Cell Therapy

The therapy will be administered intravenously

DEVICE

Clinimacs Plus

The CliniMACS Plus device is an automated cell separation tool that uses MACS Technology. It incorporates a flexible system designed for isolating clinically labeled cells using MicroBeads.

Trial Locations (1)

10430

RECRUITING

Cipto Mangunkusumo General Hospital, Jakarta Pusat

All Listed Sponsors
lead

Dr Cipto Mangunkusumo General Hospital

OTHER